Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8QJS

VHL/Elongin B/Elongin C complex with compound 155

8QJS の概要
エントリーDOI10.2210/pdb8qjs/pdb
分子名称Elongin-B, Elongin-C, von Hippel-Lindau disease tumor suppressor, ... (5 entities in total)
機能のキーワードvhl, elongin, vbc, e3 ligase, von hippel-lindau, ubiquitinase, ligase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数12
化学式量合計168104.16
構造登録者
Kerry, P.S.,Hole, A.J.,Perez-Dorado, J.I. (登録日: 2023-09-13, 公開日: 2024-01-17, 最終更新日: 2024-02-07)
主引用文献Berlin, M.,Cantley, J.,Bookbinder, M.,Bortolon, E.,Broccatelli, F.,Cadelina, G.,Chan, E.W.,Chen, H.,Chen, X.,Cheng, Y.,Cheung, T.K.,Davenport, K.,DiNicola, D.,Gordon, D.,Hamman, B.D.,Harbin, A.,Haskell, R.,He, M.,Hole, A.J.,Januario, T.,Kerry, P.S.,Koenig, S.G.,Li, L.,Merchant, M.,Perez-Dorado, I.,Pizzano, J.,Quinn, C.,Rose, C.M.,Rousseau, E.,Soto, L.,Staben, L.R.,Sun, H.,Tian, Q.,Wang, J.,Wang, W.,Ye, C.S.,Ye, X.,Zhang, P.,Zhou, Y.,Yauch, R.,Dragovich, P.S.
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.
J.Med.Chem., 67:1262-1313, 2024
Cited by
PubMed Abstract: The identification of VHL-binding proteolysis targeting chimeras (PROTACs) that potently degrade the BRM protein (also known as SMARCA2) in SW1573 cell-based experiments is described. These molecules exhibit between 10- and 100-fold degradation selectivity for BRM over the closely related paralog protein BRG1 (SMARCA4). They also selectively impair the proliferation of the H1944 "BRG1-mutant" NSCLC cell line, which lacks functional BRG1 protein and is thus highly dependent on BRM for growth, relative to the wild-type Calu6 line. experiments performed with a subset of compounds identified PROTACs that potently and selectively degraded BRM in the Calu6 and/or the HCC2302 BRG1 mutant NSCLC xenograft models and also afforded antitumor efficacy in the latter system. Subsequent PK/PD analysis established a need to achieve strong BRM degradation (>95%) in order to trigger meaningful antitumor activity . Intratumor quantitation of mRNA associated with two genes whose transcription was controlled by BRM ( and ) also supported this conclusion.
PubMed: 38180485
DOI: 10.1021/acs.jmedchem.3c01781
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.191 Å)
構造検証レポート
Validation report summary of 8qjs
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon